Answers are grounded in this paper and cite their sources.
Barriers to cancer clinical trial accrual can be prospectively identified and addressed in the development and conduct of future studies, which may potentially lead to more robust clinical trials enrollment. Investigation of patient perceptions regarding the clinical trials process and the role of third party-payers is warranted.
No takes yet. Share an insight, caveat, or question.
Lara et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: